91 related articles for article (PubMed ID: 7712683)
1. Naloxone effects on post-prandial glucose, insulin and C-peptide levels in obese subjects.
De Marinis L; Mancini A; De Luca AM; Fiumara C; Zuppi P; Sammartano L; Valle D
Diabetes Res; 1993; 23(2):83-91. PubMed ID: 7712683
[TBL] [Abstract][Full Text] [Related]
2. Intravenous insulin simulates early insulin peak and reduces post-prandial hyperglycaemia/hyperinsulinaemia in type 2 (non-insulin-dependent) diabetes mellitus.
Luzio SD; Owens DR; Vora J; Dolben J; Smith H
Diabetes Res; 1991 Feb; 16(2):63-7. PubMed ID: 1817807
[TBL] [Abstract][Full Text] [Related]
3. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
Al-Waili N
Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
[TBL] [Abstract][Full Text] [Related]
4. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
Vilsbøll T; Krarup T; Madsbad S; Holst JJ
Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
[TBL] [Abstract][Full Text] [Related]
5. Gender-specific leptinemia and its relationship with some components of the metabolic syndrome in Moroccans.
Lyoussi B; Ragala MA; Mguil M; Chraibi A; Israili ZH
Clin Exp Hypertens; 2005 May; 27(4):377-94. PubMed ID: 15921074
[TBL] [Abstract][Full Text] [Related]
6. Estimates of insulin action in normal, obese and NIDDM man: comparison of insulin and glucose infusion test, CIGMA, minimal model and glucose clamp techniques.
Davis SN; Monti L; Piatti PM; Moller N; Ng L; Coppack S; May M; Brown MD; Orskov H; Alberti KG
Diabetes Res; 1993; 23(1):1-18. PubMed ID: 7924144
[TBL] [Abstract][Full Text] [Related]
7. Postprandial paradoxical IGFBP-1 response in obese patients with Type 2 diabetes.
Lehtihet M; Efendic S; Brismar K
Clin Sci (Lond); 2008 Sep; 115(5):167-74. PubMed ID: 18208402
[TBL] [Abstract][Full Text] [Related]
8. Stepwise increase in plasma insulin and C-peptide concentrations in obese, in obese hypertensive, and in obese hypertensive diabetic subjects.
Donatelli M; Scarpinato A; Bucalo ML; Russo V; Iraci T; Vassallo G
Diabetes Res; 1991 Jul; 17(3):125-9. PubMed ID: 1841027
[TBL] [Abstract][Full Text] [Related]
9. [Behavior of C-peptide and immunoreactive insulin in essential obesity].
Gragnoli G; Signorini AM; Tanganelli I; Martinelli G
Boll Soc Ital Biol Sper; 1979 Mar; 55(6):564-70. PubMed ID: 399187
[TBL] [Abstract][Full Text] [Related]
10. Glucose intolerance in renal failure: role of endogenous opioids.
Elias AN; Vaziri ND; Pandian MR; Nawabi MA; Khamiseh G
J Lab Clin Med; 1990 Aug; 116(2):191-5. PubMed ID: 2144312
[TBL] [Abstract][Full Text] [Related]
11. Physiological elevations of plasma beta-endorphin alter glucose metabolism in obese, but not normal-weight, subjects.
Giugliano D; Cozzolino D; Salvatore T; Ceriello A; Torella R; Franchimont P; Lefebvre PJ; D'Onofrio F
Metabolism; 1992 Feb; 41(2):184-90. PubMed ID: 1736041
[TBL] [Abstract][Full Text] [Related]
12. Hyperglycemia and obesity as determinants of glucose, insulin, and glucagon responses to beta-endorphin in human diabetes mellitus.
Giugliano D; Salvatore T; Cozzolino D; Ceriello A; Torella R; D'Onofrio F
J Clin Endocrinol Metab; 1987 Jun; 64(6):1122-8. PubMed ID: 2952663
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity to beta-endorphin as a cause of human obesity.
Giugliano D; Salvatore T; Cozzolino D; Ceriello A; Torella R; D'Onofrio F
Metabolism; 1987 Oct; 36(10):974-8. PubMed ID: 2958673
[TBL] [Abstract][Full Text] [Related]
14. Metabolic response to three years of continuous, basal rate intravenous insulin infusion in type II diabetic patients.
Blackshear PJ; Shulman GI; Roussell AM; Nathan DM; Minaker KL; Rowe JW; Robbins DC; Cohen AM
J Clin Endocrinol Metab; 1985 Oct; 61(4):753-60. PubMed ID: 3897260
[TBL] [Abstract][Full Text] [Related]
15. Opiate receptors and the metabolic response to intravenous glucose.
Leslie RD; Eff C; Barnett AH; Spiliopoulos AJ; Pyke DA; Stubbs WA; Alberti KG
Diabete Metab; 1982 Sep; 8(3):235-9. PubMed ID: 6292013
[TBL] [Abstract][Full Text] [Related]
16. [Endogenous insulin secretion during the insulin-glucose test in obesity].
Custro N; Scafidi V; Calanni S; Borséllino T
Boll Soc Ital Biol Sper; 1988 Apr; 64(4):301-8. PubMed ID: 3056458
[No Abstract] [Full Text] [Related]
17. Quantitative and qualitative differences in basal and glucose- and arginine-stimulated insulin secretion in healthy subjects and different stages of NIDDM.
Ratheiser K; Reitgruber W; Komjati M; Bratusch-Marrain P; Vierhapper H; Waldhäusl WK
Acta Diabetol Lat; 1990; 27(3):197-213. PubMed ID: 2075783
[TBL] [Abstract][Full Text] [Related]
18. [Measurement of insulin sensitivity in obese or diabetic children in vivo. A comparison of three methods (author's transl)].
Dieterlen P; Desjeux JF; Giraud M; Villard S; Lestradet H
Arch Fr Pediatr; 1980; 37 Suppl 2():XXXIX-XLII. PubMed ID: 7004384
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of blood sugar and insulin reactions of obese and non-obese patients with NIDDM].
Wang H; Wu H
Zhonghua Yi Xue Za Zhi; 1989 Nov; 69(11):631-2. PubMed ID: 2699824
[No Abstract] [Full Text] [Related]
20. Hepatosplanchnic insulin kinetics in awake endotoxemic Yucatan minipigs: the "misinformed B-cell" hypothesis revisited.
Fettman MJ; Hand MS; Chandrasena LG; Cleek JL; Mason RA; Phillips RW
Circ Shock; 1984; 14(4):237-50. PubMed ID: 6391722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
